Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)

NCT00778869 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing

Interventions

BIOLOGICAL: Remicade

Sponsor

Merck Sharp & Dohme LLC